Market News - Page 233

Preliminary Results for the year ended 30 April 2022…

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for momelotinib, a potential new medicine with a proposed differentiated mechanism of action that may address the significant unmet medical needs of myelofibrosis patients with anaemia. …

Statement: Zantac (ranitidine) U.S. litigation   Notice of Voluntary Dismissal to be filed in Bayer case, first scheduled Zantac trial GSK did not settle Plaintiff…

AstraZeneca's supplemental New Drug Application (sNDA) for Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone has been accepted and granted Priority Review in the US for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC)….

16 August 2022 LONDONMETRIC PROPERTY PLC LONDONMETRIC SELLS FOUR ASSETS FOR £26 MILLION   LondonMetric Property Plc (“LondonMetric”) has sold four assets, in two separate…

Financial Report for the Half Year ended 30 June 2022…

The Board of Darktrace notes the recent media speculation and confirms that, following receipt of a number of preliminary and conditional proposals, it is in the early stages of discussions with Thoma Bravo, L.P. (“Thoma Bravo”) regarding a possible cash offer for the entire issued and to be issued share capital of the Company….

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today announces a trading update for the year ending 30 September 2022. …